This expanded understanding of furin’s function highlights novel therapeutic opportunities, particularly through dual inhibition of the furin–TGF-β/ERK axis, which may help limit tumor progression and remodel the tumor microenvironment toward a less aggressive phenotype. The gene discussed is TGFB1; the disease is neoplasm.